Pamela Fralick

Pamela Fralick
Pamela Fralick is an experienced leader who has been fostering positive change in Canada’s health sector for decades. Throughout her career, Ms Fralick has distinguished herself in a variety of senior roles. A convener and innovator, Ms Fralick is one of Canada’s leading, compassionate voices in the health sector. As the President of Innovative Medicines Canada, Ms Fralick leads the industry association for Canada’s innovative pharmaceutical companies, working with its members and communities to ensure Canadians have access to the medicines they need when they need them. Prior to joining Innovative Medicines Canada, Ms. Fralick was President and CEO of …
Pamela Fralick is an experienced leader who has been fostering positive change in Canada’s health sector for decades. Throughout her career, Ms Fralick has distinguished herself in a variety of senior roles. A convener and innovator, Ms Fralick is one of Canada’s leading, compassionate voices in the health sector. As the President of Innovative Medicines Canada, Ms Fralick leads the industry association for Canada’s innovative pharmaceutical companies, working with its members and communities to ensure Canadians have access to the medicines they need when they need them.

Prior to joining Innovative Medicines Canada, Ms. Fralick was President and CEO of the Canadian Cancer Society, Canada’s largest health charity, where she oversaw a process of intense transformation, resulting in historic changes to the operational and governance structures of the organization.

Ms Fralick previously served as president and CEO of the Canadian Healthcare Association (CHA), the Canadian Physiotherapy Association, the Collegium of Work and Learning and the Canadian Centre on Substance Abuse. At each organization, Ms. Fralick led initiatives designed to enhance sustainability and improve outcomes for their members and stakeholders. Ms Fralick has also held senior public service positions with Health Canada and the Department of National Defense.

True to her commitment to the health and well-being of Canadians, Ms Fralick has served on numerous prestigious boards and collaboratives across Canada. She was Chair of the Health Action Lobby (HEAL) and Co-chair of the Canadian Coalition for Public Health in the 21st Century (CCPH21). She has been active in many organizations as a senior volunteer, including the Centre for Addiction and Mental Health (Chair), the University of Ottawa Institute of Mental Health Research, Triathlon Canada, the International Triathlon Union as well as the Outward Bound Canada (Chair) and the Canada Dance Festival (Chair). She currently serves on the Board of Outward Bound International and the Global Advisory Council of the Commission on Accreditation of Healthcare Management Education (CAHME).

Ms Fralick has a BA in French and psychology and an MA in developmental psychology from Carleton University, as well as a Master of Public Administration (MPA) from Queen’s University. She also holds an ICD.D designation. She is trilingual – in English, French and German – and is an accomplished artist and athlete.
See more

Articles: Pamela Fralick

A New Approach to Rare Diseases in Canada

Canada / Pamela Fralick of Innovative Medicines Canada (IMC) advocates for a collaborative multi-stakeholder approach to better tackle rare diseases in Canada.   Especially in smaller provinces, it’s virtually impossible to predictably manage the affordability and accessibility of drugs necessary to treat rare disease Around the world, rare diseases are becoming easier to diagnose and treat courtesy…

Comprehensive Access to Medicines should be the Priority for National Pharmacare in Canada

Canada / Canada is the only developed country with a universal healthcare system that does not provide universal coverage of prescription drugs. With a new national ‘pharmacare’ program being proposed to remedy this situation, Pamela Fralick of Innovative Medicines Canada outlines the strengths and weaknesses of the proposal on the table and argues for a fix of…

Investing in Canadian Health: We Know the Cost, but Can We Talk About Value?

Canada / As the President of Innovative Medicines Canada, Pamela Fralick leads the industry association for Canada’s innovative pharmaceutical companies, working with its members and communities to ensure Canadians have access to the medicines they need when they need them. In her first article for PharmaBoardroom, Pamela calls for the regular assessment of the value of healthcare investment,…

See more